APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 21 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 28,825,000 | $35,498,000 | 0.69% |
| DeepCurrents Investment Group LLC | 15,079,000 | $18,525,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,996,000 | $41,869,000 | 0.36% |
| Weiss Asset Management LP | 9,000,000 | $10,980,000 | 0.28% |
| SSI INVESTMENT MANAGEMENT LLC | 3,418,000 | $4,192,000 | 0.25% |
| Baker Brothers Advisors | 46,754,000 | $57,262,000 | 0.25% |
| MACKAY SHIELDS LLC | 15,855,000 | $19,641,000 | 0.18% |
| Verition Fund Management LLC | 4,310,000 | $5,350,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 1,000,000 | $1,236,000 | 0.01% |
| GIRARD PARTNERS LTD. | 66,081 | $162,000 | 0.01% |